-
2024-512969-14-01
4
2022-05-02
Patient who underwent Allogeneic hematopoietic stem cell
transplantati
-
2024-515945-40-00
10
2022-05-02
Non small cell lung cancer
-
2023-508881-14-00
9
2022-03-21
Myeloid malignancies (acute myeloid leukemia (AML), myelodysplastic sy
-
2024-511609-44-00
10
2022-02-03
Rectum cancer
-
2024-510690-16-00
5
2022-01-31
Relapsed/refractory follicular lymphoma
-
2024-511001-28-00
4
2021-12-13
Neuroendocrine tumor
-
2023-503435-17-00
5
2021-03-31
Juvenile psoriatic arthritis
-
2024-514025-30-00
4
2021-03-25
Ocular conservative treatment for retinoblastoma
-
2023-505187-11-00
7
2021-03-01
Duchenne Muscular Dystrophy
-
2024-512229-10-00
4
2021-02-04
Takayasu arteritis
-
2024-516461-36-00
5
2021-01-27
Pregnancy associated hypertension, Pre-Eclampsia, Fetal growth restric
-
2024-514349-13-00
5
2020-10-11
Excision-autograft surgery in burn patient
-
2023-505737-26-00
5
2020-07-22
Steroid refractory Acute Graft versus host Disease
-
2022-501050-11-01
10
2020-07-13
Acute Lymphoblastic Leukaemia
-
2024-515276-12-00
5
2020-07-01
Postpartum Hemorrhage
-
2024-514603-34-00
5
2020-03-02
intermediate-risk differentiated thyroid cancer patients
-
2022-501454-11-00
5
2020-02-05
standard risk ALK-positive anaplastic large cell lymphoma (ALCL)
-
2024-516421-30-00
4
2020-02-05
Neonatal hypoxic-ischaemic encephalopathy
-
2023-507256-76-00
6
2020-01-14
Ulcerative colitis
-
2024-516266-11-00
5
2020-01-06
yeast intra-abdominal infection, peritonitis
-
2024-512321-84-00
5
2019-10-02
Patients after HSCT suffering from new or reactivated CMV or EBV or Ad
-
2024-514156-33-00
5
2019-08-20
Patients in remission for granulomatosis with polyangiitis (GPA,
Wegen
-
2024-511862-35-00
4
2019-07-19
Adults with non-contrast-enhancing diffuse brainstem gliomas with non-
-
2024-510580-28-00
5
2019-06-05
Middle or low locally advanced resectable rectal carcinoma